124 related articles for article (PubMed ID: 16052530)
21. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade.
Wu W; Onn A; Isobe T; Itasaka S; Langley RR; Shitani T; Shibuya K; Komaki R; Ryan AJ; Fidler IJ; Herbst RS; O'Reilly MS
Mol Cancer Ther; 2007 Feb; 6(2):471-83. PubMed ID: 17308046
[TBL] [Abstract][Full Text] [Related]
22. Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma.
Shen J; Zheng H; Ruan J; Fang W; Li A; Tian G; Niu X; Luo S; Zhao P
Br J Cancer; 2013 Jul; 109(1):164-71. PubMed ID: 23799852
[TBL] [Abstract][Full Text] [Related]
23. ZD6474 enhances paclitaxel antiproliferative and apoptotic effects in breast carcinoma cells.
Sarkar S; Mazumdar A; Dash R; Sarkar D; Fisher PB; Mandal M
J Cell Physiol; 2011 Feb; 226(2):375-84. PubMed ID: 20665703
[TBL] [Abstract][Full Text] [Related]
24. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
25. Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer.
Shibuya K; Komaki R; Shintani T; Itasaka S; Ryan A; Jürgensmeier JM; Milas L; Ang K; Herbst RS; O'Reilly MS
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1534-43. PubMed ID: 17889445
[TBL] [Abstract][Full Text] [Related]
26. ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib.
Yang Y; Ikezoe T; Nishioka C; Taguchi T; Zhu WG; Koeffler HP; Taguchi H
Cancer Sci; 2006 Dec; 97(12):1404-9. PubMed ID: 16995874
[TBL] [Abstract][Full Text] [Related]
27. Combination antiangiogenic and androgen deprivation therapy for prostate cancer: a promising therapeutic approach.
Nicholson B; Gulding K; Conaway M; Wedge SR; Theodorescu D
Clin Cancer Res; 2004 Dec; 10(24):8728-34. PubMed ID: 15623658
[TBL] [Abstract][Full Text] [Related]
28. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
[TBL] [Abstract][Full Text] [Related]
29. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
[TBL] [Abstract][Full Text] [Related]
30. ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity.
Ryan AJ; Wedge SR
Br J Cancer; 2005 Jun; 92 Suppl 1(Suppl 1):S6-13. PubMed ID: 15928657
[TBL] [Abstract][Full Text] [Related]
31. Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium.
Beaudry P; Nilsson M; Rioth M; Prox D; Poon D; Xu L; Zweidler-Mckay P; Ryan A; Folkman J; Ryeom S; Heymach J
Mol Cancer Ther; 2008 Feb; 7(2):418-24. PubMed ID: 18245671
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition.
Hammarsten P; Halin S; Wikstöm P; Henriksson R; Rudolfsson SH; Bergh A
Clin Cancer Res; 2006 Dec; 12(24):7431-6. PubMed ID: 17189416
[TBL] [Abstract][Full Text] [Related]
33. Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
Zhou G; Hasina R; Wroblewski K; Mankame TP; Doçi CL; Lingen MW
Cancer Prev Res (Phila); 2010 Nov; 3(11):1493-502. PubMed ID: 20978113
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.
Hou Z; Xie L; Yu L; Qian X; Liu B
Med Oncol; 2012 Jun; 29(2):886-92. PubMed ID: 21347720
[TBL] [Abstract][Full Text] [Related]
35. ZD6474, a small molecule tyrosine kinase inhibitor, potentiates the anti-tumor and anti-metastasis effects of radiation for human nasopharyngeal carcinoma.
Yang S; Wu J; Zuo Y; Tan L; Jia H; Yan H; Zhu X; Zeng M; Ma J; Huang W
Curr Cancer Drug Targets; 2010 Sep; 10(6):611-22. PubMed ID: 20491619
[TBL] [Abstract][Full Text] [Related]
36. The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.
Vitagliano D; De Falco V; Tamburrino A; Coluzzi S; Troncone G; Chiappetta G; Ciardiello F; Tortora G; Fagin JA; Ryan AJ; Carlomagno F; Santoro M
Endocr Relat Cancer; 2011 Feb; 18(1):1-11. PubMed ID: 20943719
[TBL] [Abstract][Full Text] [Related]
37. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein.
Mi Y; Lou L
Br J Cancer; 2007 Oct; 97(7):934-40. PubMed ID: 17912240
[TBL] [Abstract][Full Text] [Related]
38. ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity.
Williams KJ; Telfer BA; Brave S; Kendrew J; Whittaker L; Stratford IJ; Wedge SR
Clin Cancer Res; 2004 Dec; 10(24):8587-93. PubMed ID: 15623642
[TBL] [Abstract][Full Text] [Related]
39. The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice.
Ko J; Ross J; Awad H; Hurwitz H; Klitzman B
J Surg Res; 2005 Dec; 129(2):251-9. PubMed ID: 16140331
[TBL] [Abstract][Full Text] [Related]
40. Sequence-dependent inhibition of human colon cancer cell growth and of prosurvival pathways by oxaliplatin in combination with ZD6474 (Zactima), an inhibitor of VEGFR and EGFR tyrosine kinases.
Troiani T; Lockerbie O; Morrow M; Ciardiello F; Eckhardt SG
Mol Cancer Ther; 2006 Jul; 5(7):1883-94. PubMed ID: 16891475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
